Croda France opened in Paris in 1976 and is today located near Versailles, with commercial, logistics, accounting and administrative teams plus a local warehouse. Our manufacturing site in Chocques not only supports our customers but also local biodiversity through more than 50,000 bees onsite, with their natural honey shared with employees.
France is also home to Crodarom and Sederma, within our Beauty Actives business. Founded in 1998, Crodarom manufactures innovative plant extracts for personal care and industrial applications. Founded in 1964, Sederma develops active ingredients and innovative concepts for cosmetics. With a high performance claim substantiation laboratory, powerful in vitro, ex vivo and in vivo tests prove the efficacy of products.
Our fine fragrance business Parf’Ex, acquired by Croda subsidiary Iberchem in June 2021, is headquartered in Grass.
Our dynamic teams in France are highly supportive of local charities and communities.
Croda France SAS1, avenue de Westphalie
Tel: +33 1 301 39430
Croda Chocques S.A.S.1, rue de Lapugnoy
Tel: +33 3 21 61 84 00
Crodarom S.A.SCrodarom SAS
Parc d'Activites Les Plaines
Tel: +33 4 6648 2027
29 rue du Chemin Vert
78612 Le Perray en Yvelines Cedex
Tel: +33 1 3484 1010
Parc d'activités les Bois de Grasse
51, avenue Louison
+33 (0)4 92 42 42 52
Launch of first report on biotechnology opportunities in the personal care market
27 September 2022: The “Biotechnology: personal care market report” is the first in a series from Croda which aim to help other forward-thinking companies leverage the opportunities offered by...Read more
Jez Maiden to retire as Croda Group Finance Director; Louisa Burdett appointed as successor
7 November 2022: Jez Maiden, Group Finance Director, will be retiring from the Company during 2023 after eight years in the role, Louisa Burdett has been appointed to succeed Jez.Read more
Acquisition of Solus Biotech expands fast growth Beauty Actives business in Asia
6 February 2023: Croda International Plc (‘Croda’) announces that it has agreed to acquire Solus Biotech (‘Solus’), a global leader in premium, biotechnology-derived beauty actives.Read more